Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,839 USD | -0,12 % | -3,56 % | +64,51 % |
06/05 | CHEMOMAB THERAPEUTICS LTD. : Oppenheimer réajuste son opinion à la hausse | ZM |
10/04 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Adi Mor
CEO | Chief Executive Officer | 43 | 22/09/11 |
Sigal Fattal
DFI | Director of Finance/CFO | 53 | 01/01/20 |
Chief Tech/Sci/R&D Officer | 56 | 14/11/22 | |
Ilan Vaknin
CTO | Chief Tech/Sci/R&D Officer | - | 12/08/22 |
Jack Lawler
CTO | Chief Tech/Sci/R&D Officer | - | 04/01/22 |
Barbara Lindheim
IRC | Investor Relations Contact | - | - |
Sharon Hashmueli
LAW | General Counsel | - | 01/01/16 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Neil Cohen
BRD | Director/Board Member | 60 | 01/04/20 |
Nissim Darvish
CHM | Chairman | 59 | 16/03/21 |
Claude Nicaise
BRD | Director/Board Member | 71 | 16/03/21 |
Alan Moses
BRD | Director/Board Member | 76 | 16/03/21 |
Adi Mor
CEO | Chief Executive Officer | 43 | 22/09/11 |
Jill Quigley
BRD | Director/Board Member | 49 | 21/06/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 20 | 14 204 735 | 705 422 ( 4,966 %) | 0 | 4,966 % |
Coordonnées société
Chemomab Therapeutics Ltd.
Kiryat Atidim Building 7
6158002, Tel Aviv
+972 77 331 0156
http://www.chemomab.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+64,51 % | 11,93 M | |
+10,79 % | 116 Md | |
+11,65 % | 106 Md | |
-6,20 % | 23,89 Md | |
-2,77 % | 21,58 Md | |
-6,03 % | 18,96 Md | |
-13,41 % | 16,33 Md | |
-40,50 % | 16,96 Md | |
+6,64 % | 14,14 Md | |
+31,84 % | 12,02 Md |
- Bourse
- Actions
- Action CMMB
- Société Chemomab Therapeutics Ltd.